Fungal infections in nontransplant patients with hematologic malignancies

Brahm H Segal1, Eric J Bow, Francisco Menichetti

  • 1Division of Infectious Diseases, SUNY at Buffalo, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA. brahm.segal@roswellpark.org

Insights

Hematologic malignancy patients face significant risks from fungal infections, particularly from Candida and Aspergillus species. Emerging resistant fungal pathogens pose an increasing threat, necessitating a review of their epidemiology, diagnosis, and treatment.

Area of Science:

  • Mycology
  • Hematology
  • Infectious Diseases

Background:

  • Fungal infections are a significant cause of illness and death in patients with hematologic malignancies.
  • Candida and Aspergillus species are the primary opportunistic fungal pathogens in this vulnerable group.
  • Rare fungal pathogens resistant to standard treatments are increasingly prevalent.

Purpose of the Study:

  • To review the epidemiology of fungal infections in non-transplant hematologic malignancy patients.
  • To discuss the clinical manifestations, diagnostic approaches, and treatment strategies for major fungal pathogens.
  • To highlight the rising incidence of emerging fungal pathogens resistant to amphotericin B.

Main Methods:

  • Review of epidemiological data on fungal infections in hematologic malignancy patients.
  • Analysis of clinical presentations and diagnostic methods for common and emerging fungal pathogens.
  • Evaluation of current treatment guidelines and therapeutic options for fungal infections.

Main Results:

  • Candida and Aspergillus species are the most common fungal pathogens.
  • Dimorphic fungi and encapsulated yeasts like Cryptococcus neoformans cause disseminated infections in immunocompromised hosts.
  • Emerging pathogens such as Trichosporon, Fusarium, Scedosporium, and dark-walled molds are increasingly identified and often resistant to amphotericin B.

Conclusions:

  • Fungal infections remain a critical concern for patients with hematologic malignancies.
  • Early diagnosis and appropriate treatment are crucial for improving outcomes.
  • The rise of antifungal resistance necessitates ongoing surveillance and development of new therapeutic strategies.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...